Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AstraZeneca’s Farxiga succeeds in phase 3 trial in chronic kidney disease
AstraZeneca reports positive results for Farxiga in phase 3 DAPA-CKD trial. Credit: AstraZeneca.
AstraZeneca reports positive results for Farxiga in phase 3 DAPA-CKD trial. Credit: AstraZeneca.